RGC Stock Chart & Stats
$5.54
$0.34(5.94%)
At close: 4:00 PM EDT
$5.54
$0.34(5.94%)
Day’s Range― - ―
52-Week Range$4.51 - $69.00
Previous CloseN/A
Volume14.07K
Average Volume (3M)316.53K
Market Cap
$3.33B
Enterprise Value$10.00T>
Total Cash (Recent Filing)$14.19M
Total Debt (Recent Filing)$295.81K
Price to Earnings (P/E)―
Beta-1.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield318.47%
Share Statistics
EPS (TTM)-0.02
Shares Outstanding495,884,370
10 Day Avg. Volume569,491
30 Day Avg. Volume316,533
Financial Highlights & Ratios
PEG Ratio-1.12
Price to Book (P/B)225.64
Price to Sales (P/S)0.00
P/FCF Ratio-391.41
Enterprise Value/Market Cap2.20M
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-18.11B
Enterprise Value/Ebitda-647.21M
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Regencell Bioscience News
RGC FAQ
What was Regencell Bioscience’s price range in the past 12 months?
Regencell Bioscience lowest stock price was $4.51 and its highest was $69.00 in the past 12 months.
What is Regencell Bioscience’s market cap?
Regencell Bioscience’s market cap is $3.33B.
When is Regencell Bioscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regencell Bioscience’s earnings last quarter?
Currently, no data Available
Is Regencell Bioscience overvalued?
According to Wall Street analysts Regencell Bioscience’s price is currently Overvalued.
Does Regencell Bioscience pay dividends?
Regencell Bioscience pays a Quarterly dividend of $0.22 which represents an annual dividend yield of 318.47%. See more information on Regencell Bioscience dividends here
What is Regencell Bioscience’s EPS estimate?
Regencell Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regencell Bioscience have?
Regencell Bioscience has 495,884,370 shares outstanding.
What happened to Regencell Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regencell Bioscience?
Currently, no hedge funds are holding shares in RGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Regencell Bioscience Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
RGC Sentiment 89%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Decreased
By 46.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.96%
12-Months-Change
Fundamentals
Return on Equity
-160.64%
Trailing 12-Months
Asset Growth
155.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Regencell Bioscience
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Technical Analysis
Ownership Overview
―
Insiders
0.06% Mutual Funds
<0.01% Other Institutional Investors
99.91% Public Companies and
Individual Investors